Advertisement

Topics

STAT Plus: New Sarepta CEO is top drug talent with coveted commercial expertise; Sell-side ‘confidence’ cliche

07:14 EDT 29 Jun 2017 | STAT

The board of Sarepta Therapeutics made a great choice offering the CEO job to Doug Ingram, the former Allergan president.

Original Article: STAT Plus: New Sarepta CEO is top drug talent with coveted commercial expertise; Sell-side ‘confidence’ cliche

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: New Sarepta CEO is top drug talent with coveted commercial expertise; Sell-side ‘confidence’ cliche"

Quick Search
Advertisement